COVID-19 is caused by a new coronavirus that quickly spread across the globe. The global research community responded quickly, with the Canadian Government making an initial investment of more than $50 million dollars (CAD) to COVID-19 research, including several grants made to Maritime researchers.
At the MSSU, we are working with our partners across the provincial health systems to prioritize support for Maritime researchers studying COVID-19, the pandemic response, and its impact on communities.
Researchers are working quickly and under unprecedented pressures. The MSSU is here to help. If you’re doing COVID-19 research in New Brunswick, Nova Scotia, or Prince Edward Island, we offer free research consultations.
Our staff have expertise in:
- Qualitative and Quantitative Research Methods
- Project Management
- Evidence Synthesis
- Knowledge Translation and Communications
- Patient and Public Engagement
- Privacy and Ethics
- Administrative Health Data Access and Services
Our work is collaborative by design, and we can also help researchers to connect with each other, health administrators, and policy-makers who are working in related areas. Similarly, we can support decision-makers who are looking for researchers to help with projects addressing specific evidence needs.
The rapid response to the COVID-19 pandemic means that the available information is constantly changing, as we learn more about this new disease, the efficacy of various responses, and the impact on our communities.
To help our community cope with the unprecedented volume of information, we will have created a collection of COVID-19 resources.
Need help making sense of available research? If you’re a Maritime-based researcher, you can request a research consultation with our Evidence Synthesis Coordinator.
- Survey Results on Mental Health Impacts of COVID-19 in New Brunswick (March 1, 2021)
- Transmission Characteristics of SARS-CoV-2 variants of concern: Rapid Scoping Review (March 2021)
- Planning for Community Resiliency in Recovery from COVID-19 (October 2, 2020)
- End-of-Life Care in Times of Pandemic: A Rapid Review of the Literature (April 15, 2020)
- Rapid response report on COVID-19 in New Brunswick: March 31, 2020
- Update: Rapid response report on COVID-19 in New Brunswick: April 14, 2020
- Update: Rapid response report on COVID-19 in New Brunswick: April 27, 2020
- Rapid Response Report on Dedicated Resources for COVID-19: April 8, 2020
- Rapid response report on lifting restrictions for COVID-19: April 16, 2020
- Lifting restrictions for COVID-19: Implications for New Brunswick April 26, 2020
COVID-19 Background Summaries
A series of background summaries on potential treatments for COVID-19 were created for the CO-VIC study and the Nova Scotia Therapeutics and Prophylactics Advisory Group. These summaries give a snapshot of evidence available at the time, and are typically updated on a monthly basis. Given the rapid pace of COVID-19 research, it is possible that some of the information is now out of date. If you’re interested in up-to-date information on any of these topics, please reach out to our Evidence Synthesis Coordinator, Leah Boulos at LeahM.Boulos@nshealth.ca.
- Artesunate – November 23, 2021
- Sotrovimab – November 23, 2021
- Ivermectin – November 22, 2021
- Imatinib – November 16, 2021
- Remdesivir – November 16, 2021
- Bamlanivimab – November 15, 2021
- Dexamethasone – November 15, 2021
- Baricitinib – November 8, 2021
- Casirivimab/Imdevimab – November 8, 2021
- Infliximab – November 8, 2021
- Colchicine – November 1, 2021
- Fluvoxamine – November 1, 2021
- Tocilizumab and sarilumab – November 1, 2021
- Molnupiravir – October 8, 2021
- Losartan – September 7, 2021
Staying current with rapidly changing evidence, often coming from many different sources, is a constant challenge. We are collaborating closely with the SPOR Evidence Alliance to meet the information needs of policy- and decision-makers. Below is a selection of evidence syntheses lead by Dr. Janet Curran, MSSU Science Lead for Knowledge Translation. Visit the SPOR Evidence Alliance website for a more complete list of their knowledge synthesis work to support decision-makers during COVID-19.
- Public Health Implications of SARS-CoV-2 Variants of Concern: Living Rapid Review
- Public Health and Health Systems Impacts of SARS-CoV-2 Variants of Concern: A Rapid Scoping Review and Jurisdictional Scan
- Transmission characteristics of SARS-CoV-2 variants of concern
- New report shows how COVID-19 affects mental health in New Brunswick – April 14, 2021
- MSSU supports CO-VIC Study – August 11, 2020
- Joining forces to support primary care during and after COVID-19 – July 22, 2020
- COVID-19 Rapid Response Reports support government response in New Brunswick – July 15, 2020
- New rapid literature review on end-of life care during pandemic – May 11, 2020
- NB-IRDT COVID-19 projections show good news for NB – April 16, 2020
- New MSSU COVID-19 Resource Guide – April 9, 2020
- MSSU work arrangements during COVID-19 outbreak – March 17, 2020